UBS Group »

Xenon Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 31k 46.06
2023-09-30 $201k 5.9k 34.16
2023-06-30 $189k 4.9k 38.67
2023-03-31 $165k 4.6k 35.79
2022-12-31 $184k 4.7k 39.43
2022-09-30 $123k 3.4k 35.83
2022-06-30 $76k 2.5k 30.83
2022-03-31 $53k 1.2k 43.48
2021-12-31 $56k 1.8k 31.51
2021-09-30 $16k 1.0k 15.66
2021-06-30 $19k 1.0k 18.61
2021-03-31 $18k 1.0k 18.00
2020-12-31 $27k 1.7k 15.53
2020-09-30 $23k 2.0k 11.43
2020-06-30 $30k 2.3k 13.00
2020-03-31 $7.0k 632 11.08
2019-12-31 $23k 1.8k 13.12
2019-09-30 $11k 1.2k 8.94
2019-06-30 $51k 5.1k 10.00
2019-03-31 $30k 3.0k 10.00
2018-12-31 $999 149 6.71
2018-09-30 $11k 854 13.03
2018-06-30 $8.0k 889 9.00
2017-06-30 $8.0k 2.5k 3.16
2016-09-30 $5.0k 617 8.10
2016-03-31 $8.0k 1.1k 7.23
2015-12-31 $21k 2.6k 7.99
2015-03-31 $6.0k 346 17.34